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Abstract: Diverse aetiologies of viral and bacterial
encephalitis are widely recognized as significant yet
neglected public health issues in the Mekong region. A
robust analysis of the corresponding health burden is
lacking. We retrieved 75 articles on encephalitis in the
region published in English or in French from 1965
through 2011. Review of available data demonstrated that
they are sparse and often derived from hospital-based
studies with significant recruitment bias. Almost half (35
of 75) of articles were on Japanese encephalitis virus (JEV)
alone or associated with dengue. In the Western Pacific
region the WHO reported 30,000–50,000 annual JEV cases
(15,000 deaths) between 1966 and 1996 and 4,633 cases
(200 deaths) in 2008, a decline likely related to the
introduction of JEV vaccination in China, Vietnam, or
Thailand since the 1980s. Data on dengue, scrub typhus
and rabies encephalitis, among other aetiologies, are also
reviewed and discussed. Countries of the Mekong
region are undergoing profound demographic, economic
and ecological change. As the epidemiological aspects of
Japanese encephalitis (JE) are transformed by vaccination
in some countries, highly integrated expert collaborative
research and objective data are needed to identify and
prioritize the human health, animal health and economic
burden due to JE and other pathogens associated with
encephalitides.
Introduction
Encephalitides are considered a serious public health issue in
countries of the Mekong region (here defined as Cambodia, Lao
PDR [Laos], Vietnam, Thailand, and Yunnan of PR China). This
part of the world is undergoing profound transformations due to
remarkable increases in population, tourism, energy consumption,
road networks, vehicle density, economic development and
deforestation [1–3]. In these times of competing priorities and
financial constraints for health authorities, can the burden of
encephalitis in the Mekong region be estimated?
Various aspects need to be considered when estimating disease
burden: collective versus individual burden, the cost of preventive
versus curative measures, morbidity and mortality versus financial
burden, acute versus chronic disease, human versus animal
disease, etc. With the exception of some data on Japanese
encephalitis virus, very few prevalence, incidence, cost-ascertain-
ment or clinical follow-up studies seem available on most identified
encephalitides circulating in countries of the Mekong region. We
reviewed published Medline-referenced resources on encephalitis
and meningoencephalitis and used these to complete an overview
of the epidemiological situation in this dynamic region of the
world.
Methods
In January 2012, we reviewed articles published in English or
French from 1965 to January 1, 2012 and listed in the Medline
database. The terms ‘‘Southeastern Asia/epidemiology,’’ ‘‘En-
cephalitis,’’ ‘‘Arboviral encephalitis,’’ ‘‘Encephalitis, viruses,’’ and
‘‘Anti-N-Methyl-D-Aspartate Receptor Encephalitis’’ were used
alone and in combination.
A case of acute encephalitis syndrome was defined as any person
presenting a fever with neurological signs (altered mental status
AND/OR motor deficit AND/OR sensory deficit AND/OR
seizures of new onset, excluding simple febrile seizures) of sudden
onset (fewer than seven days). Meningoencephalitis cases present
the abovementioned signs plus meningism (nuchal rigidity).
References on human and animal health were taken into
consideration. These were consulted and extracted using the
Institut Pasteur’s distance bibliographical resources or HINARI
(http://hinari-gw.who.int). Bibliographical references of consulted
articles were checked for pertinence and also reviewed, as needed.
Additional queries were made using Google for specific references
freely available on the Internet and resources identified while the
manuscript was in preparation were also reviewed.
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Results
The MeSH search query found 58,753 references for ‘‘South-
eastern Asia/epidemiology,’’ 38,160 references for ‘‘Encephalitis’’
and 140 articles for ‘‘Southeastern Asia/epidemiology’’ and
‘‘Encephalitis.’’ Of these, references were found using ‘‘Southeast-
ern Asia/epidemiology’’ and ‘‘Arboviral encephalitis’’ (N= 66)
and ‘‘Encephalitis, viruses’’ (N= 35). Seven articles were excluded
as they were in a language other than English or French, and an
additional three described neurocysticercosis, botanical repellents,
and mosquito species. A further 55 articles were excluded as their
title suggested they dealt with outbreaks or disease in countries
outside of the Mekong region: Indonesia, Malaysia, Philippines, or
Singapore. Of the 75 references examined, 35 dealt with Japanese
encephalitis virus, three with dengue, three with both and seven
with Nipah virus infection. The 27 remaining references dealt with
various encephalitides or were not detailed.
Japanese encephalitis virus surveillance and estimated
burden data
Japanese encephalitis virus (JEV) is the most important
cause of acute encephalitis in Eastern/Southern Asia. Based on a
data review for 1966–1996, the World Health Organization
(WHO) estimated that there were 68,000 (15,000 deaths) annually
[4]. Based on 1994 population figures and highly varying annual
incidence rates documented during research projects, Tsai
estimated that in 1994 there were approximately 175,000 cases,
over 43,750 deaths, and 78,750 surviving children with disability
[5]. Seroprevalence studies reviewed by WHO found almost
universal infection by early adulthood in rural endemic areas [4].
There is a high degree of uncertainty regarding the present
situation. Only 4,633 cases (200 deaths) were reported to WHO in
2008 from the Western Pacific region [6], due to some high-
endemicity countries having introduced JEV vaccination [7,8] but
certainly also to clinical misdiagnosis [9], underdiagnosis, and/or
underreporting. There are very few geographical locations in the
Mekong countries with JEV epidemiological data with vast
swathes of encephalitis terra incognita [10]. Authors have tried
to ascertain the size of the at-risk population and the estimated
annual number of JEV cases using modelling techniques [5,11–
13]. These modelling techniques far underestimate the observed
number of cases in a country like Cambodia, where vaccination is
not available countrywide and where the surface used for
cultivating rice paddy—harbouring competent vectors—has
increased by 39% between 2004 and 2011 [14]. Recently,
Campbell et al. [11] revisited and complemented Tsai’s method,
concluding that 67,897 JEV cases occurred per year worldwide.
For Cambodia, however, these estimates are based only on
published sentinel surveillance data [15], which probably provides
an incomplete picture and will lead to severe underestimation.
Using Campbell’s method, we arrive at an estimated 8,200 cases of
symptomatic infection annually for the Mekong region and 563 for
Cambodia alone (not shown). In 2012, the number of meningo-
encephalitis patients documented by the Kantha Bopha Founda-
tion hospitals alone in Phnom Penh and Siem Reap were 2,090
and 1,521, respectively (2013 phone call with D. Laurent, personal
communication). The Institut Pasteur du Cambodge (IPC) tested
samples from 317 of these patients as part of a research study,
finding JEV IgM in patients’ cerebrospinal fluid (CSF) and/or
serum in 51 (16.1%). Extrapolated to the 3,611 meningoenceph-
alitis cases, this conservative estimate yields a total number of 581
JEV cases at Kantha Bopha hospitals alone. Meningoencephalitis
cases are managed throughout Cambodia, whether in public
sector or third-tier Foundation hospitals. Another project at
Angkor Hospital for Children (Siem Reap) found 15 (15%) JEV
positivity among a series of 100 meningoencephalitis cases (blood
and/or CSF, 24 July 2013 email exchanges with V. Kumar,
personal communication).
An additional 47 (14.8%) children were positive at IPC both for
JEV and Dengue virus (DENV) IgM, for which the causative
pathogen could be either flavivirus (15 July 2013 email exchanges
with Philippe Buchy, personal communication). This illustrates the
additional difficulty of diagnosing JEV encephalitis when CSF may
contain undetectable amounts of pathogen or genetic material,
when patients arrive late in the course of the disease at hospitals
with diagnostic capability, when CSF samples are not routinely
taken in countries such as Cambodia, and when attempting
diagnosis in countries where other cross-reactive flaviviruses such
as dengue are endemoepidemic.
Clinical impact of JEV
The available JEV data are predominantly derived from
hospital-based studies and are therefore likely to underestimate
community incidence as most JEV infections are asymptomatic
and only an estimated 1 in 250–500 infections result in clinical
signs [16,17]. Those signs vary greatly, ranging from a flu-like or
dengue-like febrile syndrome—which is frequent in children in the
Mekong region—to severe encephalitis, with a case-fatality rate
(CFR) estimated at 5–40% (up to 60% for severe forms).
Neurological sequelae occur in 30–50% of survivors and are
often severe [18–22], although it seems that a majority of patients
recovered after three to five years in one large study in India [23].
It has been estimated [24] that 265,778–1,859,170 disease-
adjusted life years (DALYs) were lost to JEV worldwide in 2005.
JEV vaccination
Effective JEV vaccination was first developed in 1941 [8] and is
now readily available. Laboratory and clinical surveillance data
have shown its effectiveness as a public health measure in countries
like Japan or South Korea [7]. Data from Thailand and Vietnam
show that vaccination has transformed the epidemiology of JEV in
those countries, vastly reducing the incidence of JEV since it was
introduced or expanded in the 1990s [7,8]. The vaccine has
recently been introduced in Laos but remains to be introduced or
rolled out in the routine immunization programs of Cambodia,
Laos, and Myanmar. The vaccination of pigs for JEV could be
cost-effective from a public health point of view by decreasing the
level of circulation in the amplifying host and consecutively the
incidence in humans [13,25]. The impact of mass JEV vaccination
of swine on human health has been studied in Japan [26], showing
a reduction of JEV transmission to humans. Unfortunately the
high turnover of animals and the cost of vaccine make such
options cost-ineffective. Implementing swine vaccination in
countries like Cambodia or Laos where 70% of all pigs are raised
in small-scale farms [27] would be a serious challenge. Although
large-scale vaccination of domestic pigs may not be feasible, the
use of pigs as sentinel animals appears efficient at least in the early
detection of human outbreaks [28].
Other encephalitides
At least 90 other infectious agents are known to cause
encephalitis or severe febrile disease associated with encephalitis
signs, several of which circulate widely in Southeast Asia (Table 1).
Dengue encephalitis
The reach of dengue is expanding. The number of symptomatic
dengue patients had been estimated at 50–100 million cases each
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year worldwide [4,29]. A recent study estimated the global burden
of symptomatic cases at 96 million [interval 67.1–135.6] each year,
approximately 70% of which occur in Asia and 34% in India alone
[30]. This increase from previous WHO estimates is due in part to
undernotification [31,32], but also to increasing urban populations
in Southeast Asia [33].
In 2010, WHO reporting schemes recorded 233,912 dengue
cases (16,690 deaths) in the Mekong region (excluding southern
China) [34,35]. Dengue was estimated to cause the loss of 420
DALYs per million population per year in Thailand [36]. But a
recent study estimated 1,383,120 symptomatic cases [range
513,151–1,805,769] in the Mekong region (excluding China), for
an annual burden ranging from 130 DALY per million inhabitants
in Vietnam to 1,130 DALY per million inhabitants in Cambodia
[37]. This study confirms that dengue is a vast health and
economic burden, as found earlier, albeit on a smaller scale
[38,39].
Dengue encephalitis has only recently been accepted as a
clinical entity and may manifest itself with signs ranging from fever
with limited alteration of consciousness to severe encephalopathy
with convulsions or myelitis, often with sequelae in survivors [40–
46]. Dengue has been associated with encephalitis in 0.5–6.2% of
cases. Among 42 Thai patients with dengue encephalitis (DE),
three (7.1%) died and one (2.4%) had long-term sequelae [42]. In
other DE studies with limited sample sizes (N= 27) in Vietnam,
the CFR was 22% and short-term sequelae were observed in 29%
of cases but all recovered within seven days [45]. Of nine cases
described in another, limited study, also in Vietnam, six (66%) had
sequelae at discharge [40].
Frequent bacterial pathogens and encephalitis
Bacteria, including Mycobacterium tuberculosis and Mycoplasma
pneumoniae, tend to be neglected as causes of encephalitis. Scrub
typhus is an important—yet neglected but treatable—cause of
fever in countries of the Mekong region [47,48]. Of 72 confirmed
cases of scrub typhus with clinical records in Songkla, Thailand in
the mid-1980s, nine (12.5%) presented with neurological signs.
Murine typhus (Rickettsia typhi) and leptospirosis (Leptospira spp.)
may also cause encephalitis [49].
Rabies encephalitis
Rabies is widely enzootic throughout Southeast Asia. Canine
rabies is neglected and has re-emerged in China since 1990 [50]
(and has even emerged in Flores [51] and Bali [52,53]), causing
high morbidity (as rabid dogs bite more frequently [54]) and
economic burden and mortality (human rabies deaths) throughout
the region. With an estimated annual incidence of 5.8/100,000
population (95% CI 2.8–11.5) in Cambodia, rabies has been
estimated to cause over 800 deaths a year for a population of 14
million [55], an incidence comparable to or higher than that of
road-related deaths in developed countries [56]. As with JEV,
Table 1. Nonexhaustive list of pathogens known to have
caused human encephalitis cases published in the literature.
VIRUSES BACTERIA
Adenovirus Balamuthia mandrillaris
Al Khurma virus Bartonella henselae, B. quintana or
Bartonella bacilliformis
Bat lyssavirus Borrelia burgdorferi (Lyme disease)
California encephalitis Brucella spp.
Chandipura virus Burkholderia pseudomallei
Chikungunya virus Chlamydia pneumoniae
Cytomegalovirus Chlamydia psittaci
Dengue virus Coxiella burneti (Q Fever)
Eastern Equine Encephalitis virus Francisella tularensis
Enterovirus (incl. EV71) Leptospira spp.
Epstein-Barr virus Listeria monocytogenes
Hendra virus Mycobacterium tuberculosis
Herpes simplex virus Mycoplasma pneumoniae
Human herpesvirus 6 Pasteurella multocida
Influenza A virus Streptococcus A pyogenes
Influenza A(H5N1) virus Streptococcus group B
Influenza B virus Tropheryma whipplei
JC virus
Junin virus RICKETTSIAE
Kunjin virus Anaplasma phagocytophilum
Kyasanur Forest virus Coxiella burnetii
LaCrosse Encephalitis virus Ehrlichia chaffeensis
Lassa virus Orientia tsutsugamuchi
Lymphocytic Choriomeningitis Virus Rickettsia rickettsii
Louping Ill virus Rickettsia typhi
Measles virus Rickettsia felis
Mumps virus
Murray Valley virus PROTOZOA
Nipah virus Acanthamoeba
Norovirus Balamuthia mandrillaris
Omsk hemorrhagic fever virus Baylisascaris procyonis
Parechovirus Coccidioides immitis
Parvovirus B19 Cryptococcus neoformans, C. gattii
Poliovirus Naegleria fowleri
Powassan encephalitis virus Plasmodia spp.
Rabies and other lyssaviruses Toxocara canis
Respiratory Syncytial Virus Toxoplasma gondii
Rift Valley Fever virus Treponema pallidum
Rocio virus Trypanosoma brucei gambiense
Rotavirus Trypanosoma brucei rhodesiense
Rubella virus
Sindbis virus HELMINTHS
St Louis encephalitis virus Baylisascaris procyonis
Tick-borne encephalitis virus Gnathostoma spp.
Toscana virus Taenia solium
Usutu virus Trichinella spiralis
Varicella Zoster Virus Angiostrongylus cantonensis
Venezuelan Equine Encephalitis virus
Table 1. Cont.
VIRUSES BACTERIA
West Nile virus OTHER
Western Equine Encephalitis virus Prion disease
Yellow Fever virus
Pathogens ubiquitous or known to circulate in countries of the Mekong region
are shown in bold (completed and adapted from Tunkel et al. [91]).
doi:10.1371/journal.pntd.0002533.t001
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vaccination is available in the region but generally not readily
accessible for populations at risk.
Rare causes of encephalitis in the Mekong region
Other, less frequent encephalitides circulate in the Mekong
region. Streptococcus suis [57] can cause sporadic and self-
limiting outbreaks of meningoencephalitis, even if recent studies in
Thailand and Vietnam have shown that the disease may be
underestimated [58]. Massive epidemics of encephalitis, such as
the enterovirus serotype 71 (EV71) encephalitis outbreaks were as
well described in Cambodia, Thailand, and Vietnam in 2012 [59–
61]. Although human cases have not been identified, evidence of
Nipah virus circulation has been found in bats throughout the
lower Mekong Region [62–68]. Although it is the—or one of
the—main causes of encephalitis in studies conducted in the USA
[69–71], the United Kingdom [72], France [73] and Australia
[74], studies carried out to date in the Mekong Region and data
from Cambodia have identified little or no Herpes Simplex Virus
(February 2012 conversations with P. Buchy, personal communi-
cation). Although this relatively lower incidence may perhaps be
overshadowed by the larger incidence of tropical encephalitides,
diagnosing this pathogen remains a priority as it is one of the few
accessible to curative management, despite its incomplete effec-
tiveness even in developed countries [75–77].
Estimating the financial burden of encephalitis
The financial burden of encephalitis is significant: post-
exposure rabies vaccination and travel costs to access it can
amount to a Cambodian farmer’s monthly wage (A. Tarantola,
unpublished data), while the direct and indirect costs of JEV
encephalitis hospitalization and care can amount to nearly ten
times that [22]. Hospitalization for dengue costs half a month’s
average wage in rural Cambodia [39]. Encephalitis survivors often
present severe sequelae; consequences on a family’s income,
organization, or balance can be dire.
The impact of encephalitides in domestic animals
Encephalitic zoonoses impact animal husbandry as well.
Japanese encephalitis in pigs causes stillbirths, abortions, infertility,
and small litter sizes [78]. Furthermore, in Thailand for example,
veterinary authorities are obliged by law to cull pigs after a JEV or
a S. suis outbreak, causing further significant financial losses to pig
producers [79]. The circulation of Japanese encephalitis in pigs in
the Region is intense, principally in the countryside but
increasingly in urban areas as well [80,81]. Outbreaks of Nipah
virus would cause fatal pneumonia in pigs and would result of
culling thousands of pigs in countries with veterinary law
enforcement (like Thailand or Vietnam) as it happened in
Malaysia in 1998 [68]. To the best of our knowledge, the
economic impact of these diseases in animals and their prevention
has not been evaluated in the Mekong region.
Perspectives
Over the past six decades, research has barely improved our
understanding of enzootic circulation, vector control and etiolog-
ical curative measures for JEV [82]. It is very likely that expansion
of JEV vaccination to the remaining JEV endemic areas would be
a highly cost-effective intervention [22]. In the absence of
vaccination, the encephalitis burden will likely increase in the
coming years in most Southeast Asian countries, especially as
semi-commercial systems of pig production develop in periurban
areas [83] with growing populations [12] and increasing land use
for agriculture [84,85].
Whatever the nature and scope of the encephalitis burden in
Southeast Asia and the criterion used to assess it—morbidity,
mortality, handicap, impact on families’ budget, or livelihood—
that burden is borne principally by the same rural, economically
fragile populations with limited access to prevention and health
care. The identification of etiological agents is useful for estimating
burden and to guide research, but first and foremost to urgently
rule out treatable or preventable causes. Overall, surveillance and
diagnostic capabilities for encephalitis remain poor in most areas
of the Mekong region and beyond [6]. Although the burden of
non-infectious, autoimmune encephalitis [86] in the region
remains to be ascertained, the best laboratories worldwide
continue to only identify etiological infective agents in around
50% of cases at most [72,73,82,87–89]. Little progress in bedside
diagnostic capacities is to be expected to help treat patients in
frontline care.
Probabilistic encephalitis management protocol based on sound
clinical, epidemiological, and laboratory-based research would
benefit patients in settings with limited access to diagnostic
capacities. State-of-the-art medical and scientific collaborations
dedicated to encephalitides in the Mekong region are urgently
needed. These may be organized around three main axes: (i)
reinforced microbiological and immunological etiological investi-
gations, (ii) improved clinical and therapeutic management, and
(iii) assessment of ecoepidemiological and social determinants to
identify environmental and behavioural risk factors for acquiring
disease [90]. Well-designed frontline diagnostic strategies using
Key Learning Points
N Even in the best laboratories, aetiological agents are
diagnosed in only about 50% of patients with enceph-
alitis in Asia.
N Japanese encephalitis virus accounts for 50% of the
diagnosed pathogens in areas where vaccination is not
universally accessible.
N The burden of disease is particularly borne by children of
rural, economically fragile families.
N Multidisciplinary research may help improve knowledge
and practice in detecting, treating, and preventing
encephalitis in the Mekong region.
Five Key Papers in the Field
N Mackenzie JS (2005) Emerging zoonotic encephalitis
viruses: lessons from Southeast Asia and Oceania. J
Neurovirol 11: 434–440.
N Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K
(2009) Past, present, and future of Japanese encephalitis.
Emerg Infect Dis 15: 1–7.
N Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT,
et al. (2000) Neurological manifestations of dengue
infection. Lancet 355: 1053–1059.
N Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh
AL, et al. (2010) Causes of encephalitis and differences in
their clinical presentations in England: a multicentre,
population-based prospective study. Lancet Infect Dis
10: 835–844.
N Coker RJ, Hunter BM, Rudge JW, Liverani M, Hanvor-
avongchai P (2011) Emerging infectious diseases in
southeast Asia: regional challenges to control. Lancet
377: 599–609.
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modern biomolecular tools with high sensitivity complemented by
highly specific testing by second- or third-line, highly competent
research laboratories would provide timely diagnosis of immedi-
ately treatable aetiologies, to the patients’ direct benefit. Micro-
biological and biomolecular approaches would help describe the
distribution of pathogens and open possibilities for improved
diagnosis and treatment. Encephalitis, however, is about individ-
uals, families, and communities. Epidemiologists would make the
irreplaceable laboratory findings more accurate, representative,
and interpretable through rigorous selection and documentation of
patients. They would also add further value to these findings by
helping identify hotspots, investigate trends and outbreaks, assess
sequelae or associated risk factors, and generate a database and
map documenting which pathogen was identified where. Finally,
ecoepidemiological investigations of what are often zoonotic
pathogens using a one-health approach would provide insights
on pathogens’ circulation and prevention on a larger scale.
Such studies and collaborative projects are urgently needed to
improve human capacity, diagnostic techniques, and strategies,
and to further document the macroepidemiology of encephalitis as
well as the microepidemiology of certain pathogens, whether
known or yet to be discovered, in the Mekong region.
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